Through prospective planning and targeted data assembly, we help our clients leverage the power of pharmacokinetic/pharmacodynamic analyses, statistical modeling, and simulations to generate knowledge for decisions at critical development milestones.
Since 1992, we’ve partnered with the world’s leading pharmaceutical and biotechnology companies, the World Health Organization, and the U.S. Food and Drug Administration and provided support for development programs for over 100 drugs.